AAAAAA

   
Results: 1-12 |
Results: 12
Novel approaches in the treatment of lupus nephritis
Authors: Illei, GG Czirjak, L
Citation: Gg. Illei et L. Czirjak, Novel approaches in the treatment of lupus nephritis, EXPERT OP I, 10(6), 2001, pp. 1117-1130
Cyclophosphamide for the treatment of systemic lupus erythematosus
Authors: Takada, K Illei, GG Boumpas, DT
Citation: K. Takada et al., Cyclophosphamide for the treatment of systemic lupus erythematosus, LUPUS, 10(3), 2001, pp. 154-161
Fludarabine pharmacokinetics after subcutaneous and intravenous administration in patients with lupus nephritis
Authors: Kuo, GM Boumpas, DT Illei, GG Yarboro, C Pucino, F Burstein, AH
Citation: Gm. Kuo et al., Fludarabine pharmacokinetics after subcutaneous and intravenous administration in patients with lupus nephritis, PHARMACOTHE, 21(5), 2001, pp. 528-533
IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis
Authors: McInnes, IB Illei, GG Danning, CL Yarboro, CH Crane, M Kuroiwa, T Schlimgen, R Lee, E Foster, B Flemming, D Prussin, C Fleisher, TA Boumpas, DT
Citation: Ib. Mcinnes et al., IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis, J IMMUNOL, 167(7), 2001, pp. 4075-4082
Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis
Authors: Illei, GG Austin, HA Crane, M Collins, L Gourley, MF Yarboro, CH Vaughan, EM Kuroiwa, T Danning, CL Steinberg, AD Klippel, JH Balow, JE Boumpas, DT
Citation: Gg. Illei et al., Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis, ANN INT MED, 135(4), 2001, pp. 248-257
Novel, non-antigen-specific therapeutic approaches to autoimmune/inflammatory diseases
Authors: Illei, GG Lipsky, PE
Citation: Gg. Illei et Pe. Lipsky, Novel, non-antigen-specific therapeutic approaches to autoimmune/inflammatory diseases, CURR OP IM, 12(6), 2000, pp. 712-718
Apheresis
Authors: Illei, GG Klippel, JH
Citation: Gg. Illei et Jh. Klippel, Apheresis, RHEUM DIS C, 26(1), 2000, pp. 63
Distinct T cell/renal tubular epithelial cell interactions define differential chemokine production: Implications for tubulointerstitial injury in chronic glomerulonephritides
Authors: Kuroiwa, T Schlimgen, R Illei, GG McInnes, IB Boumpas, DT
Citation: T. Kuroiwa et al., Distinct T cell/renal tubular epithelial cell interactions define differential chemokine production: Implications for tubulointerstitial injury in chronic glomerulonephritides, J IMMUNOL, 164(6), 2000, pp. 3323-3329
Macrophage-derived cytokine and nuclear factor kappa B p65 expression in synovial membrane and skin of patients with psoriatic arthritis
Authors: Danning, CL Illei, GG Hitchon, C Greer, MR Boumpas, DT McInnes, IB
Citation: Cl. Danning et al., Macrophage-derived cytokine and nuclear factor kappa B p65 expression in synovial membrane and skin of patients with psoriatic arthritis, ARTH RHEUM, 43(6), 2000, pp. 1244-1256
CD40 ligand-activated human monocytes amplify glomerular inflammatory responses through soluble and cell-to-cell contact-dependent mechanisms
Authors: Kuroiwa, T Lee, EG Danning, CL Illei, GG McInnes, IB Boumpas, DT
Citation: T. Kuroiwa et al., CD40 ligand-activated human monocytes amplify glomerular inflammatory responses through soluble and cell-to-cell contact-dependent mechanisms, J IMMUNOL, 163(4), 1999, pp. 2168-2175
Why is the ANA result positive?
Authors: Illei, GG Klippel, JH
Citation: Gg. Illei et Jh. Klippel, Why is the ANA result positive?, B RHEUM DIS, 48(1), 1999, pp. 1-4
Novel approaches in the treatment of lupus nephritis
Authors: Illei, GG Klippel, JH
Citation: Gg. Illei et Jh. Klippel, Novel approaches in the treatment of lupus nephritis, LUPUS, 7(9), 1998, pp. 644-648
Risultati: 1-12 |